Industry Research Reports

Home > Reports > Service & Software > GMP-grade AAV Vector Manufacturing Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

GMP-grade AAV Vector Manufacturing Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Service & Software

Published Date: 2026-07-18

Pages: 124 Pages

Report ld: 6978180

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

GMP-grade AAV Vector Manufacturing Service Market Size(US$)

CAGR 2026-2032

13.2%

Market Size,2032

USD 2,060

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 979 million

Market Forecast in 2032(Value)

US$ 2,060 million

CAGR

13.2%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for GMP-grade AAV Vector Manufacturing Service was estimated to be worth US$ 865 million in 2025 and is projected to reach US$ 2060 million, growing at a CAGR of 13.2% from 2026 to 2032.

GMP-grade AAV vector manufacturing services refer to contract development and manufacturing activities performed under pharmaceutical good manufacturing practice requirements for recombinant adeno-associated viral vectors. The service scope generally includes process development, cell-bank establishment, GMP drug-substance manufacturing, purification, formulation, sterile filtration, fill and finish, quality testing, stability studies, batch release and regulatory support. Common production routes include adherent or suspension HEK293 transient transfection, stable producer-cell platforms and baculovirus-Sf9 systems. Key upstream inputs include GMP-grade transfer plasmids, Rep/Cap plasmids, helper plasmids, production cells, culture media, transfection reagents, nucleases, chromatography resins, filtration consumables, single-use bioreactors and analytical reagents. Major downstream customers include gene therapy developers, biotechnology companies, pharmaceutical companies, hospital translational platforms and research institutions, with applications covering IND submissions, clinical trials, process validation and commercial supply. The industry's overall gross margin is generally estimated at approximately 25%-40%.

The global market currently consists of large integrated CDMOs, specialized AAV manufacturers and regional cell and gene therapy service providers. Large CDMOs compete through global quality systems, multi-site manufacturing networks, commercial-batch experience and integrated fill-and-finish capabilities. Specialized AAV providers differentiate themselves through high-yield HEK293 cells, proprietary plasmid systems, capsid technologies and dedicated AAV facilities. Chinese and other Asia-Pacific providers compete primarily through cost, delivery speed, early-clinical project experience and integrated service offerings. Because clinical programs require consistent technology transfer, comparability, stability data and regulatory documentation, changing suppliers after a program enters GMP manufacturing is substantially more difficult than switching research-grade packaging vendors.

Demand growth is supported by the progression of AAV gene therapy programs into clinical development, indication expansion for approved products, tissue-specific capsid development and increasing outsourcing by small and mid-sized biotechnology companies. Neurological, ophthalmic, neuromuscular and rare metabolic diseases remain important sources of GMP projects, while dual-AAV systems, engineered capsids and gene-editing delivery create additional process-development requirements. Growth is becoming less dependent on the total number of discovery programs and more dependent on whether candidates reach IND submission, advance into later-stage trials and generate repeat manufacturing orders. Tightening expectations for product quality, manufacturing consistency, potency assays and comparability favor providers with integrated analytical, quality and regulatory capabilities.

Manufacturing technology is gradually shifting from adherent culture and highly customized workflows toward suspension culture, platform processes and stable producer-cell systems. Suspension HEK293 transient transfection remains the principal route for clinical-scale expansion, but plasmid and transfection-reagent costs, batch variability and scale-up complexity remain significant. Stable producer cells, dual-plasmid systems, baculovirus-Sf9 platforms and plasmid-free technologies may lower raw-material costs and improve consistency. Downstream competition is moving beyond vector-genome titer toward enrichment of full capsids, removal of empty and partially packaged particles and tighter control of host-cell DNA, host-cell proteins, residual plasmids and replication-competent AAV.

The main constraints include gene therapy financing and pipeline reprioritization, underutilized GMP capacity, high program attrition, elevated production costs and clinical safety events that may delay development. Some facilities built during the earlier investment cycle have experienced slower order ramp-up than initially expected, encouraging CDMOs to compete through platform processes, shorter timelines, flexible batch sizes and more aggressive commercial terms. AAV also faces inherent limitations involving payload capacity, pre-existing neutralizing antibodies, repeat dosing, high-dose toxicity and tissue-targeting efficiency. Lipid nanoparticles, nonviral delivery and other in vivo gene-editing platforms may therefore substitute for AAV in selected indications. Long-term leadership will depend more on productivity, product quality, successful regulatory filings, commercial supply capability and facility utilization than on nominal installed capacity alone.

This report provides a comprehensive view of the global market for GMP-grade AAV Vector Manufacturing Service, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The GMP-grade AAV Vector Manufacturing Service market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding GMP-grade AAV Vector Manufacturing Service.

MARKET SEGMENTATION

By Company

Thermo Fisher Scientific
Lonza
Charles River Laboratories
Catalent
AGC Biologics
SK pharmteco
OXB
Forge Biologics
Viralgen
Andelyn Biosciences
Resilience
Advanced Therapies
IDT Biologika
Matica Bio
Takara Bio
VectorBuilder
GenScript ProBio
PackGene Biotech

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

GMP Drug Substance Manufacturing
GMP Drug Substance and Fill-Finish
End-to-End CMC and Manufacturing

Segment by Application

Biotechnology Companies
Pharmaceutical Companies
Other

Segment by Category

Early Clinical Manufacturing
Late-stage Clinical Manufacturing
PPQ and Commercial Manufacturing

Segment by Division

Adherent HEK293
Suspension HEK293
Baculovirus-Sf9
Other

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.

Chapter 2: Provides a detailed analysis of the GMP-grade AAV Vector Manufacturing Service companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).

Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 5: Presents GMP-grade AAV Vector Manufacturing Service revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.

Chapter 6: Presents GMP-grade AAV Vector Manufacturing Service revenue at the country level. It provides segmented data by Type and by Application for each country/region.

Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.

Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 GMP-grade AAV Vector Manufacturing Service Product Introduction

1.2 Global GMP-grade AAV Vector Manufacturing Service Market Size Forecast (2021–2032)

1.3 GMP-grade AAV Vector Manufacturing Service Market Trends & Drivers

1.3.1 GMP-grade AAV Vector Manufacturing Service Industry Trends

1.3.2 GMP-grade AAV Vector Manufacturing Service Market Drivers & Opportunities

1.3.3 GMP-grade AAV Vector Manufacturing Service Market Challenges

1.3.4 GMP-grade AAV Vector Manufacturing Service Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global GMP-grade AAV Vector Manufacturing Service Players Revenue Ranking (2025)

2.2 Global GMP-grade AAV Vector Manufacturing Service Revenue by Company (2021–2026)

2.3 Key Companies’ R&D and Operations Footprint and Headquarters

2.4 Key Companies GMP-grade AAV Vector Manufacturing Service Product Offerings

2.5 Key Companies General Availability (GA) Timeline for GMP-grade AAV Vector Manufacturing Service

2.6 GMP-grade AAV Vector Manufacturing Service Market Competitive Analysis

2.6.1 GMP-grade AAV Vector Manufacturing Service Market Concentration Rate (2021–2026)

2.6.2 Top 5 and Top 10 Global Companies by GMP-grade AAV Vector Manufacturing Service Revenue in 2025

2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on GMP-grade AAV Vector Manufacturing Service revenue, 2025

2.7 Mergers & Acquisitions and Expansion

3 Segmentation GMP-grade AAV Vector Manufacturing Service Market Classification

3.1 Introduction by Type

3.1.1 GMP Drug Substance Manufacturing

3.1.2 GMP Drug Substance and Fill-Finish

3.1.3 End-to-End CMC and Manufacturing

3.1.4 Global GMP-grade AAV Vector Manufacturing Service Sales Value by Type

3.1.4.1 Global GMP-grade AAV Vector Manufacturing Service Sales Value by Type (2021 vs 2025 vs 2032)

3.1.4.2 Global GMP-grade AAV Vector Manufacturing Service Sales Value, by Type (2021–2032)

3.1.4.3 Global GMP-grade AAV Vector Manufacturing Service Sales Value, by Type (%), 2021–2032

3.2 Introduction by Development Stage

3.2.1 Early Clinical Manufacturing

3.2.2 Late-stage Clinical Manufacturing

3.2.3 PPQ and Commercial Manufacturing

3.2.4 Global GMP-grade AAV Vector Manufacturing Service Sales Value by Development Stage

3.2.4.1 Global GMP-grade AAV Vector Manufacturing Service Sales Value by Development Stage (2021 vs 2025 vs 2032)

3.2.4.2 Global GMP-grade AAV Vector Manufacturing Service Sales Value, by Development Stage (2021–2032)

3.2.4.3 Global GMP-grade AAV Vector Manufacturing Service Sales Value, by Development Stage (%), 2021–2032

3.3 Introduction by Production Platform

3.3.1 Adherent HEK293

3.3.2 Suspension HEK293

3.3.3 Baculovirus-Sf9

3.3.4 Other

3.3.5 Global GMP-grade AAV Vector Manufacturing Service Sales Value by Production Platform

3.3.5.1 Global GMP-grade AAV Vector Manufacturing Service Sales Value by Production Platform (2021 vs 2025 vs 2032)

3.3.5.2 Global GMP-grade AAV Vector Manufacturing Service Sales Value, by Production Platform (2021–2032)

3.3.5.3 Global GMP-grade AAV Vector Manufacturing Service Sales Value, by Production Platform (%), 2021–2032

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Biotechnology Companies

4.1.2 Pharmaceutical Companies

4.1.3 Other

4.2 Global GMP-grade AAV Vector Manufacturing Service Sales Value by Application

4.2.1 Global GMP-grade AAV Vector Manufacturing Service Sales Value by Application (2021 vs 2025 vs 2032)

4.2.2 Global GMP-grade AAV Vector Manufacturing Service Sales Value by Application (2021–2032)

4.2.3 Global GMP-grade AAV Vector Manufacturing Service Sales Value by Application (%), 2021–2032

5 Segmentation by Region

5.1 Global GMP-grade AAV Vector Manufacturing Service Sales Value by Region

5.1.1 Global GMP-grade AAV Vector Manufacturing Service Sales Value by Region: 2021 vs 2025 vs 2032

5.1.2 Global GMP-grade AAV Vector Manufacturing Service Sales Value by Region (2021–2026)

5.1.3 Global GMP-grade AAV Vector Manufacturing Service Sales Value by Region (2027–2032)

5.1.4 Global GMP-grade AAV Vector Manufacturing Service Sales Value by Region (%), 2021–2032

5.2 North America

5.2.1 North America GMP-grade AAV Vector Manufacturing Service Sales Value, 2021–2032

5.2.2 North America GMP-grade AAV Vector Manufacturing Service Sales Value by Country (%), 2025 vs 2032

5.3 Europe

5.3.1 Europe GMP-grade AAV Vector Manufacturing Service Sales Value, 2021–2032

5.3.2 Europe GMP-grade AAV Vector Manufacturing Service Sales Value by Country (%), 2025 vs 2032

5.4 Asia Pacific

5.4.1 Asia Pacific GMP-grade AAV Vector Manufacturing Service Sales Value, 2021–2032

5.4.2 Asia Pacific GMP-grade AAV Vector Manufacturing Service Sales Value by Subregion (%), 2025 vs 2032

5.5 South America

5.5.1 South America GMP-grade AAV Vector Manufacturing Service Sales Value, 2021–2032

5.5.2 South America GMP-grade AAV Vector Manufacturing Service Sales Value by Country (%), 2025 vs 2032

5.6 Middle East & Africa

5.6.1 Middle East & Africa GMP-grade AAV Vector Manufacturing Service Sales Value, 2021–2032

5.6.2 Middle East & Africa GMP-grade AAV Vector Manufacturing Service Sales Value by Country (%), 2025 vs 2032

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions GMP-grade AAV Vector Manufacturing Service Sales Value Growth Trends, 2021 vs 2025 vs 2032

6.2 Key Countries/Regions GMP-grade AAV Vector Manufacturing Service Sales Value, 2021–2032

6.3 United States

6.3.1 United States GMP-grade AAV Vector Manufacturing Service Sales Value, 2021–2032

6.3.2 United States GMP-grade AAV Vector Manufacturing Service Sales Value by Type (%), 2025 vs 2032

6.3.3 United States GMP-grade AAV Vector Manufacturing Service Sales Value by Application, 2025 vs 2032

6.4 Europe

6.4.1 Europe GMP-grade AAV Vector Manufacturing Service Sales Value, 2021–2032

6.4.2 Europe GMP-grade AAV Vector Manufacturing Service Sales Value by Type (%), 2025 vs 2032

6.4.3 Europe GMP-grade AAV Vector Manufacturing Service Sales Value by Application, 2025 vs 2032

6.5 China

6.5.1 China GMP-grade AAV Vector Manufacturing Service Sales Value, 2021–2032

6.5.2 China GMP-grade AAV Vector Manufacturing Service Sales Value by Type (%), 2025 vs 2032

6.5.3 China GMP-grade AAV Vector Manufacturing Service Sales Value by Application, 2025 vs 2032

6.6 Japan

6.6.1 Japan GMP-grade AAV Vector Manufacturing Service Sales Value, 2021–2032

6.6.2 Japan GMP-grade AAV Vector Manufacturing Service Sales Value by Type (%), 2025 vs 2032

6.6.3 Japan GMP-grade AAV Vector Manufacturing Service Sales Value by Application, 2025 vs 2032

6.7 South Korea

6.7.1 South Korea GMP-grade AAV Vector Manufacturing Service Sales Value, 2021–2032

6.7.2 South Korea GMP-grade AAV Vector Manufacturing Service Sales Value by Type (%), 2025 vs 2032

6.7.3 South Korea GMP-grade AAV Vector Manufacturing Service Sales Value by Application, 2025 vs 2032

6.8 Southeast Asia

6.8.1 Southeast Asia GMP-grade AAV Vector Manufacturing Service Sales Value, 2021–2032

6.8.2 Southeast Asia GMP-grade AAV Vector Manufacturing Service Sales Value by Type (%), 2025 vs 2032

6.8.3 Southeast Asia GMP-grade AAV Vector Manufacturing Service Sales Value by Application, 2025 vs 2032

6.9 India

6.9.1 India GMP-grade AAV Vector Manufacturing Service Sales Value, 2021–2032

6.9.2 India GMP-grade AAV Vector Manufacturing Service Sales Value by Type (%), 2025 vs 2032

6.9.3 India GMP-grade AAV Vector Manufacturing Service Sales Value by Application, 2025 vs 2032

7 Company Profiles

7.1 Thermo Fisher Scientific

7.1.1 Thermo Fisher Scientific Profile

7.1.2 Thermo Fisher Scientific Main Business

7.1.3 Thermo Fisher Scientific GMP-grade AAV Vector Manufacturing Service Products, Services, and Solutions

7.1.4 Thermo Fisher Scientific GMP-grade AAV Vector Manufacturing Service Revenue (US$ Million), 2021–2026

7.1.5 Thermo Fisher Scientific Recent Developments

7.2 Lonza

7.2.1 Lonza Profile

7.2.2 Lonza Main Business

7.2.3 Lonza GMP-grade AAV Vector Manufacturing Service Products, Services, and Solutions

7.2.4 Lonza GMP-grade AAV Vector Manufacturing Service Revenue (US$ Million), 2021–2026

7.2.5 Lonza Recent Developments

7.3 Charles River Laboratories

7.3.1 Charles River Laboratories Profile

7.3.2 Charles River Laboratories Main Business

7.3.3 Charles River Laboratories GMP-grade AAV Vector Manufacturing Service Products, Services, and Solutions

7.3.4 Charles River Laboratories GMP-grade AAV Vector Manufacturing Service Revenue (US$ Million), 2021–2026

7.3.5 Charles River Laboratories Recent Developments

7.4 Catalent

7.4.1 Catalent Profile

7.4.2 Catalent Main Business

7.4.3 Catalent GMP-grade AAV Vector Manufacturing Service Products, Services, and Solutions

7.4.4 Catalent GMP-grade AAV Vector Manufacturing Service Revenue (US$ Million), 2021–2026

7.4.5 Catalent Recent Developments

7.5 AGC Biologics

7.5.1 AGC Biologics Profile

7.5.2 AGC Biologics Main Business

7.5.3 AGC Biologics GMP-grade AAV Vector Manufacturing Service Products, Services, and Solutions

7.5.4 AGC Biologics GMP-grade AAV Vector Manufacturing Service Revenue (US$ Million), 2021–2026

7.5.5 AGC Biologics Recent Developments

7.6 SK pharmteco

7.6.1 SK pharmteco Profile

7.6.2 SK pharmteco Main Business

7.6.3 SK pharmteco GMP-grade AAV Vector Manufacturing Service Products, Services, and Solutions

7.6.4 SK pharmteco GMP-grade AAV Vector Manufacturing Service Revenue (US$ Million), 2021–2026

7.6.5 SK pharmteco Recent Developments

7.7 OXB

7.7.1 OXB Profile

7.7.2 OXB Main Business

7.7.3 OXB GMP-grade AAV Vector Manufacturing Service Products, Services, and Solutions

7.7.4 OXB GMP-grade AAV Vector Manufacturing Service Revenue (US$ Million), 2021–2026

7.7.5 OXB Recent Developments

7.8 Forge Biologics

7.8.1 Forge Biologics Profile

7.8.2 Forge Biologics Main Business

7.8.3 Forge Biologics GMP-grade AAV Vector Manufacturing Service Products, Services, and Solutions

7.8.4 Forge Biologics GMP-grade AAV Vector Manufacturing Service Revenue (US$ Million), 2021–2026

7.8.5 Forge Biologics Recent Developments

7.9 Viralgen

7.9.1 Viralgen Profile

7.9.2 Viralgen Main Business

7.9.3 Viralgen GMP-grade AAV Vector Manufacturing Service Products, Services, and Solutions

7.9.4 Viralgen GMP-grade AAV Vector Manufacturing Service Revenue (US$ Million), 2021–2026

7.9.5 Viralgen Recent Developments

7.10 Andelyn Biosciences

7.10.1 Andelyn Biosciences Profile

7.10.2 Andelyn Biosciences Main Business

7.10.3 Andelyn Biosciences GMP-grade AAV Vector Manufacturing Service Products, Services, and Solutions

7.10.4 Andelyn Biosciences GMP-grade AAV Vector Manufacturing Service Revenue (US$ Million), 2021–2026

7.10.5 Andelyn Biosciences Recent Developments

7.11 Resilience

7.11.1 Resilience Profile

7.11.2 Resilience Main Business

7.11.3 Resilience GMP-grade AAV Vector Manufacturing Service Products, Services, and Solutions

7.11.4 Resilience GMP-grade AAV Vector Manufacturing Service Revenue (US$ Million), 2021–2026

7.11.5 Resilience Recent Developments

7.12 Advanced Therapies

7.12.1 Advanced Therapies Profile

7.12.2 Advanced Therapies Main Business

7.12.3 Advanced Therapies GMP-grade AAV Vector Manufacturing Service Products, Services, and Solutions

7.12.4 Advanced Therapies GMP-grade AAV Vector Manufacturing Service Revenue (US$ Million), 2021–2026

7.12.5 Advanced Therapies Recent Developments

7.13 IDT Biologika

7.13.1 IDT Biologika Profile

7.13.2 IDT Biologika Main Business

7.13.3 IDT Biologika GMP-grade AAV Vector Manufacturing Service Products, Services, and Solutions

7.13.4 IDT Biologika GMP-grade AAV Vector Manufacturing Service Revenue (US$ Million), 2021–2026

7.13.5 IDT Biologika Recent Developments

7.14 Matica Bio

7.14.1 Matica Bio Profile

7.14.2 Matica Bio Main Business

7.14.3 Matica Bio GMP-grade AAV Vector Manufacturing Service Products, Services, and Solutions

7.14.4 Matica Bio GMP-grade AAV Vector Manufacturing Service Revenue (US$ Million), 2021–2026

7.14.5 Matica Bio Recent Developments

7.15 Takara Bio

7.15.1 Takara Bio Profile

7.15.2 Takara Bio Main Business

7.15.3 Takara Bio GMP-grade AAV Vector Manufacturing Service Products, Services, and Solutions

7.15.4 Takara Bio GMP-grade AAV Vector Manufacturing Service Revenue (US$ Million), 2021–2026

7.15.5 Takara Bio Recent Developments

7.16 VectorBuilder

7.16.1 VectorBuilder Profile

7.16.2 VectorBuilder Main Business

7.16.3 VectorBuilder GMP-grade AAV Vector Manufacturing Service Products, Services, and Solutions

7.16.4 VectorBuilder GMP-grade AAV Vector Manufacturing Service Revenue (US$ Million), 2021–2026

7.16.5 VectorBuilder Recent Developments

7.17 GenScript ProBio

7.17.1 GenScript ProBio Profile

7.17.2 GenScript ProBio Main Business

7.17.3 GenScript ProBio GMP-grade AAV Vector Manufacturing Service Products, Services, and Solutions

7.17.4 GenScript ProBio GMP-grade AAV Vector Manufacturing Service Revenue (US$ Million), 2021–2026

7.17.5 GenScript ProBio Recent Developments

7.18 PackGene Biotech

7.18.1 PackGene Biotech Profile

7.18.2 PackGene Biotech Main Business

7.18.3 PackGene Biotech GMP-grade AAV Vector Manufacturing Service Products, Services, and Solutions

7.18.4 PackGene Biotech GMP-grade AAV Vector Manufacturing Service Revenue (US$ Million), 2021–2026

7.18.5 PackGene Biotech Recent Developments

8 Industry Chain Analysis

8.1 GMP-grade AAV Vector Manufacturing Service Value Chain

8.2 GMP-grade AAV Vector Manufacturing Service Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Key Suppliers of Raw Materials

8.2.3 Cost Structure

8.3 Midstream Analysis

8.4 Downstream (Customer) Analysis

8.5 Sales Model and Sales Channelss

8.5.1 GMP-grade AAV Vector Manufacturing Service Sales Model

8.5.2 Sales Channels

8.5.3 GMP-grade AAV Vector Manufacturing Service Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. GMP-grade AAV Vector Manufacturing Service Market Trends

Table 2. GMP-grade AAV Vector Manufacturing Service Market Drivers & Opportunities

Table 3. GMP-grade AAV Vector Manufacturing Service Market Challenges

Table 4. GMP-grade AAV Vector Manufacturing Service Market Restraints

Table 5. Global GMP-grade AAV Vector Manufacturing Service Revenue by Company (US$ Million), 2021–2026

Table 6. Global GMP-grade AAV Vector Manufacturing Service Revenue Market Share by Company (2021–2026)

Table 7. Key Companies’ R&D and Operations Footprint and Headquarters

Table 8. Key Companies GMP-grade AAV Vector Manufacturing Service Product Type

Table 9. Key Companies General Availability (GA) Timeline for GMP-grade AAV Vector Manufacturing Service

Table 10. Global GMP-grade AAV Vector Manufacturing Service Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on GMP-grade AAV Vector Manufacturing Service revenue, 2025

Table 12. Mergers & Acquisitions and Expansion Plans

Table 13. Global GMP-grade AAV Vector Manufacturing Service Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)

Table 14. Global GMP-grade AAV Vector Manufacturing Service Sales Value by Type (US$ Million), 2021–2026

Table 15. Global GMP-grade AAV Vector Manufacturing Service Sales Value by Type (US$ Million), 2027–2032

Table 16. Global GMP-grade AAV Vector Manufacturing Service Sales Market Share in Value by Type (2021–2026)

Table 17. Global GMP-grade AAV Vector Manufacturing Service Sales Market Share in Value by Type (2027–2032)

Table 18. Global GMP-grade AAV Vector Manufacturing Service Sales Value by Development Stage: 2021 vs 2025 vs 2032 (US$ Million)

Table 19. Global GMP-grade AAV Vector Manufacturing Service Sales Value by Development Stage (US$ Million), 2021–2026

Table 20. Global GMP-grade AAV Vector Manufacturing Service Sales Value by Development Stage (US$ Million), 2027–2032

Table 21. Global GMP-grade AAV Vector Manufacturing Service Sales Market Share in Value by Development Stage (2021–2026)

Table 22. Global GMP-grade AAV Vector Manufacturing Service Sales Market Share in Value by Development Stage (2027–2032)

Table 23. Global GMP-grade AAV Vector Manufacturing Service Sales Value by Production Platform: 2021 vs 2025 vs 2032 (US$ Million)

Table 24. Global GMP-grade AAV Vector Manufacturing Service Sales Value by Production Platform (US$ Million), 2021–2026

Table 25. Global GMP-grade AAV Vector Manufacturing Service Sales Value by Production Platform (US$ Million), 2027–2032

Table 26. Global GMP-grade AAV Vector Manufacturing Service Sales Market Share in Value by Production Platform (2021–2026)

Table 27. Global GMP-grade AAV Vector Manufacturing Service Sales Market Share in Value by Production Platform (2027–2032)

Table 28. Global GMP-grade AAV Vector Manufacturing Service Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)

Table 29. Global GMP-grade AAV Vector Manufacturing Service Sales Value by Application (US$ Million), 2021–2026

Table 30. Global GMP-grade AAV Vector Manufacturing Service Sales Value by Application (US$ Million), 2027–2032

Table 31. Global GMP-grade AAV Vector Manufacturing Service Sales Market Share in Value by Application (2021–2026)

Table 32. Global GMP-grade AAV Vector Manufacturing Service Sales Market Share in Value by Application (2027–2032)

Table 33. Global GMP-grade AAV Vector Manufacturing Service Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032

Table 34. Global GMP-grade AAV Vector Manufacturing Service Sales Value by Region (US$ Million), 2021–2026

Table 35. Global GMP-grade AAV Vector Manufacturing Service Sales Value by Region (US$ Million), 2027–2032

Table 36. Global GMP-grade AAV Vector Manufacturing Service Sales Value by Region (%), 2021–2026

Table 37. Global GMP-grade AAV Vector Manufacturing Service Sales Value by Region (%), 2027–2032

Table 38. Key Countries/Regions GMP-grade AAV Vector Manufacturing Service Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032

Table 39. Key Countries/Regions GMP-grade AAV Vector Manufacturing Service Sales Value, (US$ Million), 2021–2026

Table 40. Key Countries/Regions GMP-grade AAV Vector Manufacturing Service Sales Value, (US$ Million), 2027–2032

Table 41. Thermo Fisher Scientific Basic Information List

Table 42. Thermo Fisher Scientific Description and Business Overview

Table 43. Thermo Fisher Scientific GMP-grade AAV Vector Manufacturing Service Products, Services, and Solutions

Table 44. Revenue (US$ Million) in GMP-grade AAV Vector Manufacturing Service Business of Thermo Fisher Scientific (2021–2026)

Table 45. Thermo Fisher Scientific Recent Developments

Table 46. Lonza Basic Information List

Table 47. Lonza Description and Business Overview

Table 48. Lonza GMP-grade AAV Vector Manufacturing Service Products, Services, and Solutions

Table 49. Revenue (US$ Million) in GMP-grade AAV Vector Manufacturing Service Business of Lonza (2021–2026)

Table 50. Lonza Recent Developments

Table 51. Charles River Laboratories Basic Information List

Table 52. Charles River Laboratories Description and Business Overview

Table 53. Charles River Laboratories GMP-grade AAV Vector Manufacturing Service Products, Services, and Solutions

Table 54. Revenue (US$ Million) in GMP-grade AAV Vector Manufacturing Service Business of Charles River Laboratories (2021–2026)

Table 55. Charles River Laboratories Recent Developments

Table 56. Catalent Basic Information List

Table 57. Catalent Description and Business Overview

Table 58. Catalent GMP-grade AAV Vector Manufacturing Service Products, Services, and Solutions

Table 59. Revenue (US$ Million) in GMP-grade AAV Vector Manufacturing Service Business of Catalent (2021–2026)

Table 60. Catalent Recent Developments

Table 61. AGC Biologics Basic Information List

Table 62. AGC Biologics Description and Business Overview

Table 63. AGC Biologics GMP-grade AAV Vector Manufacturing Service Products, Services, and Solutions

Table 64. Revenue (US$ Million) in GMP-grade AAV Vector Manufacturing Service Business of AGC Biologics (2021–2026)

Table 65. AGC Biologics Recent Developments

Table 66. SK pharmteco Basic Information List

Table 67. SK pharmteco Description and Business Overview

Table 68. SK pharmteco GMP-grade AAV Vector Manufacturing Service Products, Services, and Solutions

Table 69. Revenue (US$ Million) in GMP-grade AAV Vector Manufacturing Service Business of SK pharmteco (2021–2026)

Table 70. SK pharmteco Recent Developments

Table 71. OXB Basic Information List

Table 72. OXB Description and Business Overview

Table 73. OXB GMP-grade AAV Vector Manufacturing Service Products, Services, and Solutions

Table 74. Revenue (US$ Million) in GMP-grade AAV Vector Manufacturing Service Business of OXB (2021–2026)

Table 75. OXB Recent Developments

Table 76. Forge Biologics Basic Information List

Table 77. Forge Biologics Description and Business Overview

Table 78. Forge Biologics GMP-grade AAV Vector Manufacturing Service Products, Services, and Solutions

Table 79. Revenue (US$ Million) in GMP-grade AAV Vector Manufacturing Service Business of Forge Biologics (2021–2026)

Table 80. Forge Biologics Recent Developments

Table 81. Viralgen Basic Information List

Table 82. Viralgen Description and Business Overview

Table 83. Viralgen GMP-grade AAV Vector Manufacturing Service Products, Services, and Solutions

Table 84. Revenue (US$ Million) in GMP-grade AAV Vector Manufacturing Service Business of Viralgen (2021–2026)

Table 85. Viralgen Recent Developments

Table 86. Andelyn Biosciences Basic Information List

Table 87. Andelyn Biosciences Description and Business Overview

Table 88. Andelyn Biosciences GMP-grade AAV Vector Manufacturing Service Products, Services, and Solutions

Table 89. Revenue (US$ Million) in GMP-grade AAV Vector Manufacturing Service Business of Andelyn Biosciences (2021–2026)

Table 90. Andelyn Biosciences Recent Developments

Table 91. Resilience Basic Information List

Table 92. Resilience Description and Business Overview

Table 93. Resilience GMP-grade AAV Vector Manufacturing Service Products, Services, and Solutions

Table 94. Revenue (US$ Million) in GMP-grade AAV Vector Manufacturing Service Business of Resilience (2021–2026)

Table 95. Resilience Recent Developments

Table 96. Advanced Therapies Basic Information List

Table 97. Advanced Therapies Description and Business Overview

Table 98. Advanced Therapies GMP-grade AAV Vector Manufacturing Service Products, Services, and Solutions

Table 99. Revenue (US$ Million) in GMP-grade AAV Vector Manufacturing Service Business of Advanced Therapies (2021–2026)

Table 100. Advanced Therapies Recent Developments

Table 101. IDT Biologika Basic Information List

Table 102. IDT Biologika Description and Business Overview

Table 103. IDT Biologika GMP-grade AAV Vector Manufacturing Service Products, Services, and Solutions

Table 104. Revenue (US$ Million) in GMP-grade AAV Vector Manufacturing Service Business of IDT Biologika (2021–2026)

Table 105. IDT Biologika Recent Developments

Table 106. Matica Bio Basic Information List

Table 107. Matica Bio Description and Business Overview

Table 108. Matica Bio GMP-grade AAV Vector Manufacturing Service Products, Services, and Solutions

Table 109. Revenue (US$ Million) in GMP-grade AAV Vector Manufacturing Service Business of Matica Bio (2021–2026)

Table 110. Matica Bio Recent Developments

Table 111. Takara Bio Basic Information List

Table 112. Takara Bio Description and Business Overview

Table 113. Takara Bio GMP-grade AAV Vector Manufacturing Service Products, Services, and Solutions

Table 114. Revenue (US$ Million) in GMP-grade AAV Vector Manufacturing Service Business of Takara Bio (2021–2026)

Table 115. Takara Bio Recent Developments

Table 116. VectorBuilder Basic Information List

Table 117. VectorBuilder Description and Business Overview

Table 118. VectorBuilder GMP-grade AAV Vector Manufacturing Service Products, Services, and Solutions

Table 119. Revenue (US$ Million) in GMP-grade AAV Vector Manufacturing Service Business of VectorBuilder (2021–2026)

Table 120. VectorBuilder Recent Developments

Table 121. GenScript ProBio Basic Information List

Table 122. GenScript ProBio Description and Business Overview

Table 123. GenScript ProBio GMP-grade AAV Vector Manufacturing Service Products, Services, and Solutions

Table 124. Revenue (US$ Million) in GMP-grade AAV Vector Manufacturing Service Business of GenScript ProBio (2021–2026)

Table 125. GenScript ProBio Recent Developments

Table 126. PackGene Biotech Basic Information List

Table 127. PackGene Biotech Description and Business Overview

Table 128. PackGene Biotech GMP-grade AAV Vector Manufacturing Service Products, Services, and Solutions

Table 129. Revenue (US$ Million) in GMP-grade AAV Vector Manufacturing Service Business of PackGene Biotech (2021–2026)

Table 130. PackGene Biotech Recent Developments

Table 131. Revenue (US$ Million) in GMP-grade AAV Vector Manufacturing Service Business of Company 40 (2021–2026)

Table 132. Company 40 Recent Developments

Table 133. Key Raw Materials Lists

Table 134. Key Suppliers of Raw Materials Lists

Table 135. GMP-grade AAV Vector Manufacturing Service Downstream Customers

Table 136. GMP-grade AAV Vector Manufacturing Service Distributors List

Table 137. Research Programs/Design for This Report

Table 138. Key Data Information from Secondary Sources

Table 139. Key Data Information from Primary Sources

List of Figures

Figure 1. GMP-grade AAV Vector Manufacturing Service Product Picture

Figure 2. Global GMP-grade AAV Vector Manufacturing Service Sales Value, 2021 vs 2025 vs 2032 (US$ Million)

Figure 3. Global GMP-grade AAV Vector Manufacturing Service Sales Value (US$ Million), 2021–2032

Figure 4. GMP-grade AAV Vector Manufacturing Service Report Years Considered

Figure 5. Global GMP-grade AAV Vector Manufacturing Service Players Revenue Ranking (US$ Million), 2025

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by GMP-grade AAV Vector Manufacturing Service Revenue in 2025

Figure 7. GMP-grade AAV Vector Manufacturing Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 8. GMP Drug Substance Manufacturing Picture

Figure 9. GMP Drug Substance and Fill-Finish Picture

Figure 10. End-to-End CMC and Manufacturing Picture

Figure 11. Global GMP-grade AAV Vector Manufacturing Service Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032

Figure 12. Global GMP-grade AAV Vector Manufacturing Service Sales Value Market Share by Type, 2025 & 2032

Figure 13. Early Clinical Manufacturing Picture

Figure 14. Late-stage Clinical Manufacturing Picture

Figure 15. PPQ and Commercial Manufacturing Picture

Figure 16. Global GMP-grade AAV Vector Manufacturing Service Sales Value by Development Stage (US$ Million), 2021 vs 2025 vs 2032

Figure 17. Global GMP-grade AAV Vector Manufacturing Service Sales Value Market Share by Development Stage, 2025 & 2032

Figure 18. Adherent HEK293 Picture

Figure 19. Suspension HEK293 Picture

Figure 20. Baculovirus-Sf9 Picture

Figure 21. Other Picture

Figure 22. Global GMP-grade AAV Vector Manufacturing Service Sales Value by Production Platform (US$ Million), 2021 vs 2025 vs 2032

Figure 23. Global GMP-grade AAV Vector Manufacturing Service Sales Value Market Share by Production Platform, 2025 & 2032

Figure 24. Product Picture of Biotechnology Companies

Figure 25. Product Picture of Pharmaceutical Companies

Figure 26. Product Picture of Other

Figure 27. Global GMP-grade AAV Vector Manufacturing Service Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032

Figure 28. Global GMP-grade AAV Vector Manufacturing Service Sales Value Market Share by Application, 2025 & 2032

Figure 29. North America GMP-grade AAV Vector Manufacturing Service Sales Value (US$ Million), 2021–2032

Figure 30. North America GMP-grade AAV Vector Manufacturing Service Sales Value by Country (%), 2025 vs 2032

Figure 31. Europe GMP-grade AAV Vector Manufacturing Service Sales Value (US$ Million), 2021–2032

Figure 32. Europe GMP-grade AAV Vector Manufacturing Service Sales Value by Country (%), 2025 vs 2032

Figure 33. Asia Pacific GMP-grade AAV Vector Manufacturing Service Sales Value (US$ Million), 2021–2032

Figure 34. Asia Pacific GMP-grade AAV Vector Manufacturing Service Sales Value by Subregion (%), 2025 vs 2032

Figure 35. South America GMP-grade AAV Vector Manufacturing Service Sales Value (US$ Million), 2021–2032

Figure 36. South America GMP-grade AAV Vector Manufacturing Service Sales Value by Country (%), 2025 vs 2032

Figure 37. Middle East & Africa GMP-grade AAV Vector Manufacturing Service Sales Value (US$ Million), 2021–2032

Figure 38. Middle East & Africa GMP-grade AAV Vector Manufacturing Service Sales Value by Country (%), 2025 vs 2032

Figure 39. Key Countries/Regions GMP-grade AAV Vector Manufacturing Service Sales Value (%), 2021–2032

Figure 40. United States GMP-grade AAV Vector Manufacturing Service Sales Value (US$ Million), 2021–2032

Figure 41. United States GMP-grade AAV Vector Manufacturing Service Sales Value by Type (%), 2025 vs 2032

Figure 42. United States GMP-grade AAV Vector Manufacturing Service Sales Value by Application (%), 2025 vs 2032

Figure 43. Europe GMP-grade AAV Vector Manufacturing Service Sales Value (US$ Million), 2021–2032

Figure 44. Europe GMP-grade AAV Vector Manufacturing Service Sales Value by Type (%), 2025 vs 2032

Figure 45. Europe GMP-grade AAV Vector Manufacturing Service Sales Value by Application (%), 2025 vs 2032

Figure 46. China GMP-grade AAV Vector Manufacturing Service Sales Value (US$ Million), 2021–2032

Figure 47. China GMP-grade AAV Vector Manufacturing Service Sales Value by Type (%), 2025 vs 2032

Figure 48. China GMP-grade AAV Vector Manufacturing Service Sales Value by Application (%), 2025 vs 2032

Figure 49. Japan GMP-grade AAV Vector Manufacturing Service Sales Value (US$ Million), 2021–2032

Figure 50. Japan GMP-grade AAV Vector Manufacturing Service Sales Value by Type (%), 2025 vs 2032

Figure 51. Japan GMP-grade AAV Vector Manufacturing Service Sales Value by Application (%), 2025 vs 2032

Figure 52. South Korea GMP-grade AAV Vector Manufacturing Service Sales Value (US$ Million), 2021–2032

Figure 53. South Korea GMP-grade AAV Vector Manufacturing Service Sales Value by Type (%), 2025 vs 2032

Figure 54. South Korea GMP-grade AAV Vector Manufacturing Service Sales Value by Application (%), 2025 vs 2032

Figure 55. Southeast Asia GMP-grade AAV Vector Manufacturing Service Sales Value (US$ Million), 2021–2032

Figure 56. Southeast Asia GMP-grade AAV Vector Manufacturing Service Sales Value by Type (%), 2025 vs 2032

Figure 57. Southeast Asia GMP-grade AAV Vector Manufacturing Service Sales Value by Application (%), 2025 vs 2032

Figure 58. India GMP-grade AAV Vector Manufacturing Service Sales Value (US$ Million), 2021–2032

Figure 59. India GMP-grade AAV Vector Manufacturing Service Sales Value by Type (%), 2025 vs 2032

Figure 60. India GMP-grade AAV Vector Manufacturing Service Sales Value by Application (%), 2025 vs 2032

Figure 61. GMP-grade AAV Vector Manufacturing Service Value Chain

Figure 62. GMP-grade AAV Vector Manufacturing Service Cost Structure

Figure 63. Channels of Distribution (Direct Sales, and Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global GMP-grade AAV Vector Manufacturing Service market? zhanKai

The top companies in the global GMP-grade AAV Vector Manufacturing Service market are Thermo Fisher Scientific、Lonza、Charles River Laboratories.

Which region is expected to have the highest market share? shouQi

What is the annual compound growth rate of the global GMP-grade AAV Vector Manufacturing Service market size from 2026 to 2032? shouQi

What was the global market size of GMP-grade AAV Vector Manufacturing Service in 2026? shouQi

What was the global market size of GMP-grade AAV Vector Manufacturing Service in 2032? shouQi

Related Reports

Global GMP-grade AAV Vector Manufacturing Service Market Research Report 2026
The global GMP-grade AAV Vector Manufacturing Service market was valued at US$ 865 million in 2025 and is anticipated to reach US$ 2060 million by 2032, at a CAGR of 13.2% from 2026 to 2032.
Published Date: 2026-07-18
Pages: 129
USD 2900.00
(Single User License)
Global GMP-grade AAV Vector Manufacturing Service Market Outlook, In‑Depth Analysis & Forecast to 2032
The global GMP-grade AAV Vector Manufacturing Service market is projected to grow from US$ 865 million in 2025 to US$ 2060 million by 2032, at a CAGR of 13.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-07-18
Pages: 148
USD 4900.00
(Single User License)
Global GMP-grade AAV Vector Manufacturing Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global GMP-grade AAV Vector Manufacturing Service market size was US$ 865 million in 2025 and is forecast to reach a readjusted size of US$ 2060 million by 2032 with a CAGR of 13.2% during the forecast period 2026-2032.
Published Date: 2026-07-18
Pages: 132
USD 4250.00
(Single User License)

Global GMP-grade AAV Vector Manufacturing Service Market Research Report 2026
The global GMP-grade AAV Vector Manufacturing Service market was valued at US$ 865 million in 2025 and is anticipated to reach US$ 2060 million by 2032, at a CAGR of 13.2% from 2026 to 2032.
Published: 2026-07-18
Pages: 129
USD 2900.00 (Single User License)
Global GMP-grade AAV Vector Manufacturing Service Market Outlook, In‑Depth Analysis & Forecast to 2032
The global GMP-grade AAV Vector Manufacturing Service market is projected to grow from US$ 865 million in 2025 to US$ 2060 million by 2032, at a CAGR of 13.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-07-18
Pages: 148
USD 4900.00 (Single User License)
Global GMP-grade AAV Vector Manufacturing Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global GMP-grade AAV Vector Manufacturing Service market size was US$ 865 million in 2025 and is forecast to reach a readjusted size of US$ 2060 million by 2032 with a CAGR of 13.2% during the forecast period 2026-2032.
Published: 2026-07-18
Pages: 132
USD 4250.00 (Single User License)